Unknown

Dataset Information

0

Scaffold-mediated delivery for non-viral mRNA vaccines.


ABSTRACT: mRNA is increasingly being recognized as a promising alternative to pDNA in gene vaccinations. Only recently, owing to the needs of cancer immunotherapies, has the biomaterials/gene delivery community begun to develop new biomaterial strategies for immunomodulation. Here, we report a novel way to use implantable porous scaffolds as a local gene delivery depot to enhance mRNA vaccine immunization in vitro, and in vivo when compared with conventional bolus injections. We first evaluated transfection efficiencies of single-stranded mRNA condensed and charge neutralized with two lipids (Lipofectamine Messenger MAXTM LM-MM and StemfectTM SF) and two cationic polymers (in vivo-jetPEI™, Poly (?-amino ester)) as gene carriers. As SF demonstrated highest in vitro transfection and cell viability, it was selected for subsequent porous polymer scaffold-loading trials. Enhanced in vitro transfection of SF:mRNA nanoparticle-loaded poly (2-hydroxyethyl methacrylate) (pHEMA) scaffolds was also observed with a DC2.4 cell line. Improved sustained local release and local transgene expression were also demonstrated with SF:mRNA nanoparticle-loaded pHEMA scaffolds in vivo compared with bolus injections. Our results suggest that mRNA polyplex-loaded scaffolds may be a superior alternative to either repeated bolus immunizations or ex vivo transfection cell immunotherapies.

SUBMITTER: Chen R 

PROVIDER: S-EPMC6309225 | biostudies-literature | 2018 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Scaffold-mediated delivery for non-viral mRNA vaccines.

Chen Ruying R   Zhang Hong H   Yan Jingxuan J   Bryers James D JD  

Gene therapy 20180921 8


mRNA is increasingly being recognized as a promising alternative to pDNA in gene vaccinations. Only recently, owing to the needs of cancer immunotherapies, has the biomaterials/gene delivery community begun to develop new biomaterial strategies for immunomodulation. Here, we report a novel way to use implantable porous scaffolds as a local gene delivery depot to enhance mRNA vaccine immunization in vitro, and in vivo when compared with conventional bolus injections. We first evaluated transfecti  ...[more]

Similar Datasets

| S-EPMC6369635 | biostudies-literature
| S-EPMC7995055 | biostudies-literature
| S-EPMC7836001 | biostudies-literature
| S-EPMC8195316 | biostudies-literature
| S-EPMC8473183 | biostudies-literature
| S-EPMC7573213 | biostudies-literature
| S-EPMC7334939 | biostudies-literature
| S-EPMC8211807 | biostudies-literature
| S-EPMC7076378 | biostudies-literature
| S-EPMC8386155 | biostudies-literature